Annual EBITDA
-$6.88 M
-$5.51 M-400.36%
December 31, 2022
Summary
- As of February 10, 2025, HILS annual EBITDA is -$6.88 million, with the most recent change of -$5.51 million (-400.36%) on December 31, 2022.
- During the last 3 years, HILS annual EBITDA has fallen by -$5.43 million (-374.48%).
Performance
HILS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$2.33 M
+$351.80 K+13.12%
June 30, 2023
Summary
- As of February 10, 2025, HILS quarterly EBITDA is -$2.33 million, with the most recent change of +$351.80 thousand (+13.12%) on June 30, 2023.
- Over the past year, HILS quarterly EBITDA has dropped by -$693.50 thousand (-42.37%).
Performance
HILS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$8.91 M
-$693.50 K-8.44%
June 30, 2023
Summary
- As of February 10, 2025, HILS TTM EBITDA is -$8.91 million, with the most recent change of -$693.50 thousand (-8.44%) on June 30, 2023.
- Over the past year, HILS TTM EBITDA has dropped by -$8.01 million (-895.81%).
Performance
HILS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
HILS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -400.4% | -42.4% | -895.8% |
| 3 y3 years | -374.5% | -560.7% | -2425.2% |
| 5 y5 years | -374.5% | -560.7% | -2425.2% |
HILS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +400.4% | at low | -186.0% | +15.1% | +1325.7% | at low |
| 5 y | 5-year | +400.4% | at low | -186.0% | +15.1% | +2425.2% | at low |
| alltime | all time | +400.4% | at low | -186.0% | +15.1% | +2425.2% | at low |
Hillstream BioPharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$2.33 M(-13.1%) | -$8.91 M(+8.4%) |
| Mar 2023 | - | -$2.68 M(+51.8%) | -$8.21 M(+19.3%) |
| Dec 2022 | -$6.88 M(+400.4%) | -$1.77 M(-17.0%) | -$6.88 M(+186.2%) |
| Sep 2022 | - | -$2.13 M(+30.0%) | -$2.40 M(+168.8%) |
| Jun 2022 | - | -$1.64 M(+21.1%) | -$894.40 K(+43.2%) |
| Mar 2022 | - | -$1.35 M(-149.8%) | -$624.70 K(-54.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$1.38 M(-36.6%) | $2.71 M(-539.0%) | -$1.38 M(-73.9%) |
| Sep 2021 | - | -$617.60 K(-54.8%) | -$5.28 M(+5.3%) |
| Jun 2021 | - | -$1.37 M(-35.0%) | -$5.01 M(+37.5%) |
| Mar 2021 | - | -$2.10 M(+76.7%) | -$3.64 M(+136.3%) |
| Dec 2020 | -$2.17 M(+49.7%) | -$1.19 M(+237.3%) | -$1.54 M(+337.3%) |
| Sep 2020 | - | -$352.70 K | -$352.70 K |
| Dec 2019 | -$1.45 M | - | - |
FAQ
- What is Hillstream BioPharma annual EBITDA?
- What is the all time high annual EBITDA for Hillstream BioPharma?
- What is Hillstream BioPharma annual EBITDA year-on-year change?
- What is Hillstream BioPharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Hillstream BioPharma?
- What is Hillstream BioPharma quarterly EBITDA year-on-year change?
- What is Hillstream BioPharma TTM EBITDA?
- What is the all time high TTM EBITDA for Hillstream BioPharma?
- What is Hillstream BioPharma TTM EBITDA year-on-year change?
What is Hillstream BioPharma annual EBITDA?
The current annual EBITDA of HILS is -$6.88 M
What is the all time high annual EBITDA for Hillstream BioPharma?
Hillstream BioPharma all-time high annual EBITDA is -$1.38 M
What is Hillstream BioPharma annual EBITDA year-on-year change?
Over the past year, HILS annual EBITDA has changed by -$5.51 M (-400.36%)
What is Hillstream BioPharma quarterly EBITDA?
The current quarterly EBITDA of HILS is -$2.33 M
What is the all time high quarterly EBITDA for Hillstream BioPharma?
Hillstream BioPharma all-time high quarterly EBITDA is $2.71 M
What is Hillstream BioPharma quarterly EBITDA year-on-year change?
Over the past year, HILS quarterly EBITDA has changed by -$693.50 K (-42.37%)
What is Hillstream BioPharma TTM EBITDA?
The current TTM EBITDA of HILS is -$8.91 M
What is the all time high TTM EBITDA for Hillstream BioPharma?
Hillstream BioPharma all-time high TTM EBITDA is -$352.70 K
What is Hillstream BioPharma TTM EBITDA year-on-year change?
Over the past year, HILS TTM EBITDA has changed by -$8.01 M (-895.81%)